The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 9, 2014, Pages 1992-2005

  Vervloessem, Tamara ^a   Yule, David I ^b   Bultynck, Geert ^a   Parys, Jan B ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Apoptosis; Cancer; Heart; IP3; Secretion; Senescence

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR TYPE 2; PROTEIN BCL 2; PROTEIN KINASE C; UNCLASSIFIED DRUG; BCL2 PROTEIN, HUMAN; BCL2 PROTEIN, MOUSE; CALCIUM; IP3R2 PROTEIN, MOUSE;

APOPTOSIS; B LYMPHOCYTE; BINDING AFFINITY; CELL AGING; CELL DEATH; CYTOSOL; ENDOPLASMIC RETICULUM; HEART ARRHYTHMIA; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SECRETORY CELL; SIGNAL TRANSDUCTION; TUMOR GROWTH; ANIMAL; ANTIBODY SPECIFICITY; CALCIUM SIGNALING; CARDIOMEGALY; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; APOPTOSIS; ARRHYTHMIAS, CARDIAC; CALCIUM; CALCIUM SIGNALING; CARDIOMEGALY; ENDOPLASMIC RETICULUM; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MICE; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84952629360     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.12.006     Document Type: Review

References (192)

1. 2+ release channels. Physiol. Rev. 2007, 87:593-658.
2. Parys J.B., De Smedt H. Inositol 1,4,5-trisphosphate and its receptors. Adv. Exp. Med. Biol. 2012, 740:255-279.
3. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000, 1:11-21.
4. 400. Nature 1989, 342:32-38.
5. 3 receptor. EMBO J. 1991, 10:3199-3206.
6. 3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J. Biol. Chem. 1993, 268:11356-11363.
7. 3 receptor. Biochim. Biophys. Acta 2004, 1742:89-102.
8. Taylor C.W., Genazzani A.A., Morris S.A. Expression of inositol trisphosphate receptors. Cell Calcium 1999, 26:237-251.
9. Patel S., Joseph S.K., Thomas A.P. Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium 1999, 25:247-264.
10. 3. J. Biol. Chem. 1994, 269:28613-28619.
11. De Smedt H., Missiaen L., Parys J.B., Bootman M.D., Mertens L., Van Den Bosch L., Casteels R. Determination of relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction. J. Biol. Chem. 1994, 269:21691-21698.
12. Wojcikiewicz R.J. Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types. J. Biol. Chem. 1995, 270:11678-11683.
13. De Smedt H., Missiaen L., Parys J.B., Henning R.H., Sienaert I., Vanlingen S., Gijsens A., Himpens B., Casteels R. Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. Biochem. J. 1997, 322:575-583.
14. Ivanova H., Vervliet T., Missiaen L., Parys J.B., De Smedt H., Bultynck G. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim. Biophys. Acta 2014, 1843:2164-2183.
15. Sugiyama T., Yamamoto-Hino M., Miyawaki A., Furuichi T., Mikoshiba K., Hasegawa M. Subtypes of inositol 1,4,5-trisphosphate receptor in human hematopoietic cell lines: dynamic aspects of their cell-type specific expression. FEBS Lett. 1994, 349:191-196.
16. Lee B., Jonas J.C., Weir G.C., Laychock S.G. Glucose regulates expression of inositol 1,4,5-trisphosphate receptor isoforms in isolated rat pancreatic islets. Endocrinology 1999, 140:2173-2182.
17. 2+-ATPase and inositol 1,4,5-trisphosphate receptor isoforms in vascular endothelial cells. Cell Calcium 1999, 25:371-380.
18. 3) receptor subtypes at rat colonic epithelium. Cell Calcium 2007, 41:303-315.
19. 2+ transport genes in platelets and endothelial cells in hypertension. Hypertension 2001, 37:135-141.
20. Steffl M., Schweiger M., Amselgruber W.M. Oestrous cycle-regulated expression of inositol 1,4,5-trisphosphate receptor type 2 in the pig ovary. Acta Histochem. 2004, 106:137-144.
21. 3 receptors in rodent cerebellum. Pflugers Arch. 2007, 454:415-425.
22. Vermassen E., Parys J.B., Mauger J.P. Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol. Cell. 2004, 96:3-17.
23. 2+ release by reversible phosphorylation and dephosphorylation. Biochim. Biophys. Acta 2009, 1793:959-970.
24. Yule D.I., Betzenhauser M.J., Joseph S.K. Linking structure to function: recent lessons from inositol 1,4,5-trisphosphate receptor mutagenesis. Cell Calcium 2010, 47:469-479.
25. Bezprozvanny I. The inositol 1,4,5-trisphosphate receptors. Cell Calcium 2005, 38:261-272.
26. Laflamme K., Domingue O., Guillemette B.I., Guillemette G. Immunohistochemical localization of type 2 inositol 1,4,5-trisphosphate receptor to the nucleus of different mammalian cells. J. Cell. Biochem. 2002, 85:219-228.
27. Leite M.F., Thrower E.C., Echevarria W., Koulen P., Hirata K., Bennett A.M., Ehrlich B.E., Nathanson M.H. Nuclear and cytosolic calcium are regulated independently. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2975-2980.
28. Duncan R.S., Hwang S.Y., Koulen P. Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. Int. J. Biochem. Cell Biol. 2007, 39:1852-1862.
29. 2+ waves in rat hepatocytes. Gastroenterology 2002, 122:1088-1100.
30. Gerasimenko O., Gerasimenko J. New aspects of nuclear calcium signalling. J. Cell Sci. 2004, 117:3087-3094.
31. Bootman M.D., Fearnley C., Smyrnias I., MacDonald F., Roderick H.L. An update on nuclear calcium signalling. J. Cell Sci. 2009, 122:2337-2350.
32. Bengtson C.P., Bading H. Nuclear calcium signaling. Adv. Exp. Med. Biol. 2012, 970:377-405.
33. Echevarria W., Leite M.F., Guerra M.T., Zipfel W.R., Nathanson M.H. Regulation of calcium signals in the nucleus by a nucleoplasmic reticulum. Nat. Cell Biol. 2003, 5:440-446.
34. 2+ signalling in the mammalian heart. J. Physiol. 2007, 584:601-611.
35. Morikawa K., Ohbayashi T., Nakagawa M., Konishi Y., Makino Y., Yamada M., Miyawaki A., Furuichi T., Mikoshiba K., Tamura T. Transcription initiation sites and promoter structure of the mouse type 2 inositol 1,4,5-trisphosphate receptor gene. Gene 1997, 196:181-185.
36. 3R2) expression during cardiac remodeling. J. Biol. Chem. 2014, 289:6188-6198.
37. 3 receptor 2 expression in dendritic cell migration. Cell. Physiol. Biochem. 2014, 33:222-236.
38. 2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors. Neuroscience 2011, 175:281-291.
39. 3 receptor. Biochem. J. 1998, 334:559-563.
40. Chan J., Yamazaki H., Ishiyama N., Seo M.D., Mal T.K., Michikawa T., Mikoshiba K., Ikura M. Structural studies of inositol 1,4,5-trisphosphate receptor: coupling ligand binding to channel gating. J. Biol. Chem. 2010, 285:36092-36099.
41. Iwai M., Tateishi Y., Hattori M., Mizutani A., Nakamura T., Futatsugi A., Inoue T., Furuichi T., Michikawa T., Mikoshiba K. Molecular cloning of mouse type 2 and type 3 inositol 1,4,5-trisphosphate receptors and identification of a novel type 2 receptor splice variant. J. Biol. Chem. 2005, 280:10305-10317.
42. Wojcikiewicz R.J., Furuichi T., Nakade S., Mikoshiba K., Nahorski S.R. Muscarinic receptor activation down-regulates the type I inositol 1,4,5-trisphosphate receptor by accelerating its degradation. J. Biol. Chem. 1994, 269:7963-7969.
43. Sipma H., Deelman L., De Smedt H., Missiaen L., Parys J.B., Vanlingen S., Henning R.H., Casteels R. Agonist-induced down-regulation of type 1 and type 3 inositol 1,4,5-trisphosphate receptors in A7r5 and DDT1 MF-2 smooth muscle cells. Cell Calcium 1998, 23:11-21.
44. 3) receptor. Br. J. Pharmacol. 2014, 171:3298-3312.
45. 3 receptors: the search for structure. Trends Biochem. Sci. 2004, 29:210-219.
46. Iwai M., Michikawa T., Bosanac I., Ikura M., Mikoshiba K. Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors. J. Biol. Chem. 2007, 282:12755-12764.
47. 3 receptor isoforms. Biochem. J. 2000, 346:275-280.
48. 3 receptor subtypes. EMBO J. 1999, 18:1303-1308.
49. 2+ oscillations in vascular myocytes. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1567-1575.
50. 3R2 in rat portal vein myocytes. Pflugers Arch. 2008, 456:277-283.
51. Ramos-Franco J., Fill M., Mignery G.A. Isoform-specific function of single inositol 1,4,5-trisphosphate receptor channels. Biophys. J. 1998, 75:834-839.
52. Tu H., Wang Z., Nosyreva E., De Smedt H., Bezprozvanny I. Functional characterization of mammalian inositol 1,4,5-trisphosphate receptor isoforms. Biophys. J. 2005, 88:1046-1055.
53. Wojcikiewicz R.J., Luo S.G. Differences among type I, II, and III inositol-1,4,5-trisphosphate receptors in ligand-binding affinity influence the sensitivity of calcium stores to inositol-1,4,5-trisphosphate. Mol. Pharmacol. 1998, 53:656-662.
54. Nerou E.P., Riley A.M., Potter B.V., Taylor C.W. Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor. Biochem. J. 2001, 355:59-69.
55. 2+ dependence of inositol 1,4,5-trisphosphate-induced Ca release in smooth muscle cells of the guinea pig taenia caeci. J. Gen. Physiol. 1990, 95:1103-1122.
56. Finch E.A., Turner T.J., Goldin S.M. Calcium as a coagonist of inositol 1,4,5-trisphosphate-induced calcium release. Science 1991, 252:443-446.
57. 3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 1991, 351:751-754.
58. Parys J.B., Sernett S.W., DeLisle S., Snyder P.M., Welsh M.J., Campbell K.P. Isolation, characterization, and localization of the inositol 1,4,5-trisphosphate receptor protein in Xenopus laevis oocytes. J. Biol. Chem. 1992, 267:18776-18782.
59. Ramos-Franco J., Bare D., Caenepeel S., Nani A., Fill M., Mignery G. Single-channel function of recombinant type 2 inositol 1,4, 5-trisphosphate receptor. Biophys. J. 2000, 79:1388-1399.
60. Tu H., Wang Z., Bezprozvanny I. Modulation of mammalian inositol 1,4,5-trisphosphate receptor isoforms by calcium: a role of calcium sensor region. Biophys. J. 2005, 88:1056-1069.
61. Smith J.B., Smith L., Higgins B.L. Temperature and nucleotide dependence of calcium release by myo-inositol 1,4,5-trisphosphate in cultured vascular smooth muscle cells. J. Biol. Chem. 1985, 260:14413-14416.
62. 2+ store membrane of saponin-treated guinea pig peritoneal macrophages by inositol 1,4,5-trisphosphate. J. Biochem. 1985, 97:1575-1582.
63. Ehrlich B.E., Watras J. Inositol 1,4,5-trisphosphate activates a channel from smooth muscle sarcoplasmic reticulum. Nature 1988, 336:583-586.
64. Ferris C.D., Huganir R.L., Snyder S.H. Calcium flux mediated by purified inositol 1,4,5-trisphosphate receptor in reconstituted lipid vesicles is allosterically regulated by adenine nucleotides. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:2147-2151.
65. Missiaen L., Parys J.B., De Smedt H., Himpens B., Casteels R. Inhibition of inositol trisphosphate-induced calcium release by caffeine is prevented by ATP. Biochem. J. 1994, 300:81-84.
66. Iino M. Effects of adenine nucleotides on inositol 1,4,5-trisphosphate-induced calcium release in vascular smooth muscle cells. J. Gen. Physiol. 1991, 98:681-698.
67. Bezprozvanny I., Ehrlich B.E. ATP modulates the function of inositol 1,4,5-trisphosphate-gated channels at two sites. Neuron 1993, 10:1175-1184.
68. Missiaen L., Parys J.B., De Smedt H., Sienaert I., Sipma H., Vanlingen S., Maes K., Casteels R. Effect of adenine nucleotides on myo-inositol-1,4,5-trisphosphate-induced calcium release. Biochem. J. 1997, 325:661-666.
69. 2+ release by type-2 and type-3 inositol (1, 4, 5)-triphosphate receptors. Differing ATP sensitivities and molecular determinants of action. J. Biol. Chem. 2008, 283:21579-21587.
70. Betzenhauser M.J., Wagner L.E., Park H.S., Yule D.I. ATP regulation of type-1 inositol 1,4,5-trisphosphate receptor activity does not require walker A-type ATP-binding motifs. J. Biol. Chem. 2009, 284:16156-16163.
71. Maes K., Missiaen L., De Smet P., Vanlingen S., Callewaert G., Parys J.B., De Smedt H. Differential modulation of inositol 1,4,5-trisphosphate receptor type 1 and type 3 by ATP. Cell Calcium 2000, 27:257-267.
72. 3 receptors. J. Gen. Physiol. 2001, 117:435-446.
73. Mak D.O., McBride S., Foskett J.K. ATP regulation of recombinant type 3 inositol 1,4,5-trisphosphate receptor gating. J. Gen. Physiol. 2001, 117:447-456.
74. Walker J.E., Saraste M., Runswick M.J., Gay N.J. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1982, 1:945-951.
75. Maeda N., Kawasaki T., Nakade S., Yokota N., Taguchi T., Kasai M., Mikoshiba K. Structural and functional characterization of inositol 1,4,5- trisphosphate receptor channel from mouse cerebellum. J. Biol. Chem. 1991, 266:1109-1116.
76. Maes K., Missiaen L., Parys J.B., De Smet P., Sienaert I., Waelkens E., Callewaert G., De Smedt H. Mapping of the ATP-binding sites on inositol 1,4,5-trisphosphate receptor type 1 and type 3 homotetramers by controlled proteolysis and photoaffinity labeling. J. Biol. Chem. 2001, 276:3492-3497.
77. Maes K., Missiaen L., Parys J.B., Sienaert I., Bultynck G., Zizi M., De Smet P., Casteels R., De Smedt H. Adenine-nucleotide binding sites on the inositol 1,4,5-trisphosphate receptor bind caffeine, but not adenophostin A or cyclic ADP-ribose. Cell Calcium 1999, 25:143-152.
78. 2+ activation. J. Biol. Chem. 1999, 274:22231-22237.
79. 2+ and ATP. J. Physiol. 2012, 590:3245-3259.
80. 2+ release to ATP in pancreatic acinar cells. J. Biol. Chem. 2008, 283:26081-26088.
81. 2+ release through inositol 1,4,5-trisphosphate receptors by adenine nucleotides in parotid acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302:G97-G104.
82. Alzayady K.J., Wagner L.E., Chandrasekhar R., Monteagudo A., Godiska R., Tall G.G., Joseph S.K., Yule D.I. Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits. J. Biol. Chem. 2013, 288:29772-29784.
83. Khan M.T., Wagner L., Yule D.I., Bhanumathy C.D., Joseph S.K. Akt kinase phosphorylation of inositol 1,4,5-trisphosphate receptors. J. Biol. Chem. 2006, 281:3731-3737.
84. 2+ release and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2427-2432.
85. Betzenhauser M.J., Yule D.I. Regulation of inositol 1,4,5-trisphosphate receptors by phosphorylation and adenine nucleotides. Curr. Top. Membr. 2010, 66C:273-298.
86. Walaas S.I., Nairn A.C., Greengard P. PCPP-260, a Purkinje cell-specific cyclic AMP-regulated membrane phosphoprotein of Mr 260,000. J. Neurosci. 1986, 6:954-961.
87. Mignery G.A., Newton C.L., Archer B.T., Südhof T.C. Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 1990, 265:12679-12685.
88. Ferris C.D., Cameron A.M., Bredt D.S., Huganir R.L., Snyder S.H. Inositol 1,4,5-trisphosphate receptor is phosphorylated by cyclic AMP-dependent protein kinase at serines 1755 and 1589. Biochem. Biophys. Res. Commun. 1991, 175:192-198.
89. Tang T.S., Tu H., Wang Z., Bezprozvanny I. Modulation of type 1 inositol (1,4,5)-trisphosphate receptor function by protein kinase A and protein phosphatase 1α. J. Neurosci. 2003, 23:403-415.
90. - splice variants. J. Biol. Chem. 2003, 278:45811-45817.
91. Wagner L.E., Joseph S.K., Yule D.I. Regulation of single inositol 1,4,5-trisphosphate receptor channel activity by protein kinase A phosphorylation. J. Physiol. 2008, 586:3577-3596.
92. Wagner L.E., Li W.H., Joseph S.K., Yule D.I. Functional consequences of phosphomimetic mutations at key cAMP-dependent protein kinase phosphorylation sites in the type 1 inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 2004, 279:46242-46252.
93. 2+ signaling. J. Biol. Chem. 2002, 277:1340-1348.
94. 2+ release in AR4-2J cells. J. Cell. Biochem. 2007, 101:609-618.
95. 2+ mobilization in permeabilized hepatocytes. Biochem. J. 1993, 293:413-422.
96. Wojcikiewicz R.J., Luo S.G. Phosphorylation of inositol 1,4,5-trisphosphate receptors by cAMP-dependent protein kinase. Type I, II, and III receptors are differentially susceptible to phosphorylation and are phosphorylated in intact cells. J. Biol. Chem. 1998, 273:5670-5677.
97. Betzenhauser M.J., Fike J.L., Wagner L.E., Yule D.I. Protein kinase A increases type-2 inositol 1,4,5-trisphosphate receptor activity by phosphorylation of serine 937. J. Biol. Chem. 2009, 284:25116-25125.
98. Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Large-scale phosphorylation analysis of mouse liver. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1488-1493.
99. 2+ signaling in non-excitable cells. Cell Calcium 2003, 34:431-444.
100. 2+/calmodulin-dependent protein kinase II. Biochem. J. 2002, 364:593-611.
101. 2+ signals for facilitation. J. Cell Biol. 2005, 171:537-547.
102. Maier L.S., Bers D.M. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J. Mol. Cell. Cardiol. 2002, 34:919-939.
103. Ferris C.D., Huganir R.L., Bredt D.S., Cameron A.M., Snyder S.H. Inositol trisphosphate receptor: phosphorylation by protein kinase C and calcium calmodulin-dependent protein kinases in reconstituted lipid vesicles. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:2232-2235.
104. 2+ release by CaMKII in Xenopus oocytes. Pflugers Arch. 2001, 441:796-801.
105. Zhu D.M., Tekle E., Chock P.B., Huang C.Y. Reversible phosphorylation as a controlling factor for sustaining calcium oscillations in HeLa cells: involvement of calmodulin-dependent kinase II and a calyculin A-inhibitable phosphatase. Biochemistry 1996, 35:7214-7223.
106. Bare D.J., Kettlun C.S., Liang M., Bers D.M., Mignery G.A. Cardiac type 2 inositol 1,4,5-trisphosphate receptor. Interaction and modulation by calcium/calmodulin-dependent protein kinase II. J. Biol. Chem. 2005, 280:15912-15920.
107. 2+/calmodulin-dependent protein kinase II (CaMKII)-mediated phosphorylation. J. Biol. Chem. 2012, 287:39419-39428.
108. Bootman M.D., Roderick H.L. Why, where, and when do cardiac myocytes express inositol 1,4,5-trisphosphate receptors?. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H579-H581.
109. 2+ signaling in cardiac myocyte excitation-transcription coupling. J. Clin. Invest. 2006, 116:675-682.
110. Vermassen E., Fissore R.A., Nadif Kasri N., Vanderheyden V., Callewaert G., Missiaen L., Parys J.B., De Smedt H. Regulation of the phosphorylation of the inositol 1,4,5-trisphosphate receptor by protein kinase C. Biochem. Biophys. Res. Commun. 2004, 319:888-893.
111. Matter N., Ritz M.F., Freyermuth S., Rogue P., Malviya A.N. Stimulation of nuclear protein kinase C leads to phosphorylation of nuclear inositol 1,4,5-trisphosphate receptor and accelerated calcium release by inositol 1,4,5-trisphosphate from isolated rat liver nuclei. J. Biol. Chem. 1993, 268:732-736.
112. 2+ in pancreatoma AR4-2J cells. J. Endocrinol. 2007, 192:659-668.
113. 3 receptors by cAMP. J. Cell Biol. 2008, 183:297-311.
114. Tovey S.C., Dedos S.G., Rahman T., Taylor E.J., Pantazaka E., Taylor C.W. Regulation of inositol 1,4,5-trisphosphate receptors by cAMP independent of cAMP-dependent protein kinase. J. Biol. Chem. 2010, 285:12979-12989.
115. Wilson B.S., Pfeiffer J.R., Smith A.J., Oliver J.M., Oberdorf J.A., Wojcikiewicz R.J. Calcium-dependent clustering of inositol 1,4,5-trisphosphate receptors. Mol. Biol. Cell 1998, 9:1465-1478.
116. 3 receptors. Chaos 2009, 19:037103.
117. 2+ waves in cultured astrocytes. J. Neurochem. 1997, 68:2317-2327.
118. Pantazaka E., Taylor C.W. Differential distribution, clustering, and lateral diffusion of subtypes of the inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 2011, 286:23378-23387.
119. Yule D.I., Ernst S.A., Ohnishi H., Wojcikiewicz R.J. Evidence that zymogen granules are not a physiologically relevant calcium pool. Defining the distribution of inositol 1,4,5-trisphosphate receptors in pancreatic acinar cells. J. Biol. Chem. 1997, 272:9093-9098.
120. i waves. J. Biol. Chem. 1997, 272:15765-15770.
121. 3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 2005, 309:2232-2234.
122. Zhang X., Wen J., Bidasee K.R., Besch H.R., Wojcikiewicz R.J., Lee B., Rubin R.P. Ryanodine and inositol trisphosphate receptors are differentially distributed and expressed in rat parotid gland. Biochem. J. 1999, 340:519-527.
123. 2+ initiation site of ductal epithelium of submandibular gland. J. Cell Biol. 1998, 141:135-142.
124. Inaba T., Hisatsune C., Sasaki Y., Ogawa Y., Ebisui E., Ogawa N., Matsui M., Takeuchi T., Mikoshiba K., Tsubota K. Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. PLoS ONE 2014, 9:e99205.
125. 3 receptors. Eur. J. Neurosci. 2008, 27:2665-2675.
126. 3R2 function inhibits sweat secretion in both humans and mice. J. Clin. Invest. 2014, 124:4773-4780.
127. Shibao K., Hirata K., Robert M.E., Nathanson M.H. Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis. Gastroenterology 2003, 125:1175-1187.
128. Li M., Miyawaki A., Yamamoto-Hino M., Yasutomi D., Furuichi T., Hasegawa M., Mikoshiba K. Differential cellular expression of three types of inositol 1,4,5-trisphosphate receptor in rat gastrointestinal epithelium. Biomed. Res. 1996, 17:45-51.
129. Williams J.A., Yule D.I. Stimulus-secretion coupling in pancreatic acinar cells. Physiology of the gastrointestinal tract 2012, 1361-1398. Academic Press, San Diego. 5th edition. E.L.R. Johnson (Ed.).
130. Melvin J.E., Yule D., Shuttleworth T., Begenisich T. Regulation of fluid and electrolyte secretion in salivary gland acinar cells. Annu. Rev. Physiol. 2005, 67:445-469.
131. 2+ gradients triggering unidirectional fluid secretion from exocrine pancreas. Nature 1990, 348:735-738.
132. 2+ waves and oscillations in exocrine pancreas. Cell 1993, 74:669-677.
133. 2+ oscillations in exocrine cells evoked by agonists and inositol trisphosphate. Cell 1993, 74:661-668.
134. Kruglov E.A., Gautam S., Guerra M.T., Nathanson M.H. Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes. Hepatology 2011, 54:1790-1799.
135. 2+ waves. J. Biol. Chem. 2007, 282:10057-10067.
136. 3 receptors that may modulate excitation-contraction coupling in the heart. Curr. Biol. 2000, 10:939-942.
137. Uchida K., Aramaki M., Nakazawa M., Yamagishi C., Makino S., Fukuda K., Nakamura T., Takahashi T., Mikoshiba K., Yamagishi H. Gene knock-outs of inositol 1,4,5-trisphosphate receptors types 1 and 2 result in perturbation of cardiogenesis. PLoS ONE 2010, 5:e12500.
138. 2+/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 2001, 105:863-875.
139. Bushdid P.B., Osinska H., Waclaw R.R., Molkentin J.D., Yutzey K.E. NFATc3 and NFATc4 are required for cardiac development and mitochondrial function. Circ. Res. 2003, 92:1305-1313.
140. Nakazawa M., Uchida K., Aramaki M., Kodo K., Yamagishi C., Takahashi T., Mikoshiba K., Yamagishi H. Inositol 1,4,5-trisphosphate receptors are essential for the development of the second heart field. J. Mol. Cell. Cardiol. 2011, 51:58-66.
141. 2+ signalling and the generation of arrhythmias in rat atrial myocytes. J. Physiol. 2002, 541:395-409.
142. 2+ signalling in cat atrial excitation-contraction coupling and arrhythmias. J. Physiol. 2004, 555:607-615.
143. 3)-receptor type 2-deficient mice. Circ. Res. 2005, 96:1274-1281.
144. Proven A., Roderick H.L., Conway S.J., Berridge M.J., Horton J.K., Capper S.J., Bootman M.D. Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes. J. Cell Sci. 2006, 119:3363-3375.
145. 2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H596-H604.
146. 2+ transients and arrhythmias associated with cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11406-11411.
147. 3R expression underlies enhanced calcium fluxes and spontaneous extra-systolic calcium release events in hypertrophic cardiac myocytes. Channels (Austin) 2010, 4:67-71.
148. 2+ release is a nexus for hypertrophic signaling in cardiac myocytes. Mol. Cell 2009, 33:472-482.
149. 3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J. Cell Biol. 2012, 199:783-798.
150. 3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ. Res. 2010, 107:659-666.
151. 2+ in the heart: contraction versus intracellular signaling. J. Clin. Invest. 2006, 116:623-626.
152. 2+ release and beyond. Apoptosis 2007, 12:951-968.
153. Harr M.W., Distelhorst C.W. Apoptosis and autophagy: decoding calcium signals that mediate life or death. Cold Spring Harb. Perspect. Biol. 2010, 2:a005579.
154. 3 receptor-mitochondria connection in apoptosis and autophagy. Biochim. Biophys. Acta 2011, 1813:1003-1013.
155. Jayaraman T., Marks A.R. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol. Cell. Biol. 1997, 17:3005-3012.
156. 2+ release and apoptosis. Cell Death Dis. 2012, 3:e304.
157. Csordás G., Thomas A.P., Hajnóczky G. Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO J. 1999, 18:96-108.
158. 2+ channels. J. Cell Biol. 2006, 175:901-911.
159. 3 receptor as a hub for Bcl-2 family proteins in cell death control and beyond. Sci. Signal. 2014, 7:e4.
160. 2+ signaling and disease. Cell Calcium 2011, 50:234-241.
161. 3Rs and beyond. Cell. Mol. Life Sci. 2013, 70:1171-1183.
162. 3 receptors. Biochim. Biophys. Acta 2013, 1835:180-193.
163. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999, 284:339-343.
164. Jayaraman T., Marks A.R. Calcineurin is downstream of the inositol 1,4,5-trisphosphate receptor in the apoptotic and cell growth pathways. J. Biol. Chem. 2000, 275:6417-6420.
165. Datta S.R., Katsov A., Hu L., Petros A., Fesik S.W., Yaffe M.B., Greenberg M.E. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell 2000, 6:41-51.
166. 2+ levels in colorectal cancer cell lines. J. Cell Sci. 2014, 127:1607-1619.
167. Giorgi C., Ito K., Lin H.K., Santangelo C., Wieckowski M.R., Lebiedzinska M., Bononi A., Bonora M., Duszynski J., Bernardi R., Rizzuto R., Tacchetti C., Pinton P., Pandolfi P.P. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010, 330:1247-1251.
168. 2+ influx in Bcl-2-overexpressing cells. J. Cell Biol. 2000, 148:857-862.
169. 3 receptors are involved in uranyl acetate induced apoptosis in HEK 293 cells. Toxicology 2009, 262:73-79.
170. 3 receptor types 1 and 2. Acta Physiol. (Oxf.) 2013, 208:350-361.
171. 3) receptors by reactive oxygen species. J. Biol. Chem. 2014, 289:8170-8181.
172. 3R-derived peptide targeting the BH4 domain of Bcl-2. Cell Death Dis. 2013, 4:e632.
173. Akl H., Vervloessem T., Kiviluoto S., Bittremieux M., Parys J.B., De Smedt H., Bultynck G. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum. Biochim. Biophys. Acta 2014, 1843:2240-2252.
174. Chen R., Valencia I., Zhong F., McColl K.S., Roderick H.L., Bootman M.D., Berridge M.J., Conway S.J., Holmes A.B., Mignery G.A., Velez P., Distelhorst C.W. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J. Cell Biol. 2004, 166:193-203.
175. 3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol. Cell 2008, 31:255-265.
176. Rong Y.P., Bultynck G., Aromolaran A.S., Zhong F., Parys J.B., De Smedt H., Mignery G.A., Roderick H.L., Bootman M.D., Distelhorst C.W. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14397-14402.
177. 2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. Cell Death Differ. 2012, 19:295-309.
178. Rong Y.P., Barr P., Yee V.C., Distelhorst C.W. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. Biochim. Biophys. Acta 2009, 1793:971-978.
179. 3 receptor interaction. Blood 2011, 117:2924-2934.
180. Xu S., Cai Y., Wei Y. mTOR signaling from cellular senescence to organismal aging. Aging Dis. 2014, 5:263-273.
181. Ben-Porath I., Weinberg R.A. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 2004, 113:8-13.
182. Rufini A., Tucci P., Celardo I., Melino G. Senescence and aging: the critical roles of p53. Oncogene 2013, 32:5129-5143.
183. Burgess D.J. Senescence: tumorigenesis under surveillance. Nat. Rev. Cancer 2012, 12:6.
184. Serrano M. Cancer: final act of senescence. Nature 2011, 479:481-482.
185. Ben-Porath I., Weinberg R.A. The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol. 2005, 37:961-976.
186. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., Beach D., Serrano M. Tumour biology: senescence in premalignant tumours. Nature 2005, 436:642.
187. Kang T.W., Yevsa T., Woller N., Hoenicke L., Wuestefeld T., Dauch D., Hohmeyer A., Gereke M., Rudalska R., Potapova A., Iken M., Vucur M., Weiss S., Heikenwalder M., Khan S., Gil J., Bruder D., Manns M., Schirmacher P., Tacke F., Ott M., Luedde T., Longerich T., Kubicka S., Zender L. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011, 479:547-551.
188. Wiel C., Lallet-Daher H., Gitenay D., Gras B., Le Calve B., Augert A., Ferrand M., Prevarskaya N., Simonnet H., Vindrieux D., Bernard D. Endoplasmic reticulum calcium release through ITPR2 channels leads to mitochondrial calcium accumulation and senescence. Nat. Commun. 2014, 5:3792.
189. Perez P.J., Ramos-Franco J., Fill M., Mignery G.A. Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J. Biol. Chem. 1997, 272:23961-23969.
190. Sharp A.H., Nucifora F.C., Blondel O., Sheppard C.A., Zhang C., Snyder S.H., Russell J.T., Ryugo D.K., Ross C.A. Differential cellular expression of isoforms of inositol 1,4,5-triphosphate receptors in neurons and glia in brain. J. Comp. Neurol. 1999, 406:207-220.
191. Monkawa T., Hayashi M., Miyawaki A., Sugiyama T., Yamamoto-Hino M., Hasegawa M., Furuichi T., Mikoshiba K., Saruta T. Localization of inositol 1,4,5-trisphosphate receptors in the rat kidney. Kidney Int. 1998, 53:296-301.
192. Parys J.B., De Smedt H., Missiaen L., Bootman M.D., Sienaert I., Casteels R. Rat basophilic leukemia cells as model system for inositol 1,4,5-trisphosphate receptor IV, a receptor of the type II family: functional comparison and immunological detection. Cell Calcium 1995, 17:239-249.